Announcements Trials
Browse Landscape

Phase

Phase 1 26Phase 2 13Phase 3 7Phase EARLY_PHASE1 3Phase NA 2Phase 4 2

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Pancreatic Neoplasms 1Colorectal Neoplasia 1Barrett Esophagus 1

Interventions

Magnetic Resonance Spectroscopy 61Cyclophosphamide 57pembrolizumab 39fludarabine 38Radiotherapy 30Nivolumab 30Biopsy 27Metformin 23Fluorodeoxyglucose F18 22Bevacizumab 22Specimen Handling 21Temozolomide 18Cisplatin 18Radiosurgery 17Carboplatin 16Fluorouracil 15Paclitaxel 14Dexamethasone 14Radiation 13Gemcitabine 13Etoposide 13Rituximab 12Positron Emission Tomography Computed Tomography 12Letrozole 12Irinotecan 12gallium 68 PSMA-11 11durvalumab 11atezolizumab 11X-Rays 11Surgical Procedures, Operative 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Interventional × Omeprazole × Clear all
NCT06378398 2026-03-13

A Trial of Omeprazole and Low Dose Aspirin to Identify Colorectal Biomarkers of Preventive Efficacy

University of Michigan Rogel Cancer Center

Phase EARLY_PHASE1 Completed
21 enrolled
Gastrointestinal

Colorectal Neoplasia

NCT04930991 2026-01-08

OU202005AJ

University of Oklahoma

Phase EARLY_PHASE1 Recruiting
60 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT01465113 2016-03-10

Vitamin D Supplementation on 15-Prostaglandin Dehydrogenase Expression in Barrett's Esophagus

Case Comprehensive Cancer Center

Phase EARLY_PHASE1 Completed
26 enrolled
Gastrointestinal

Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡